Transient commensal clonal interactions can drive tumor metastasis.
Amphiregulin
/ metabolism
Animals
Ascites
/ pathology
Carcinogenesis
/ pathology
Carcinoma, Renal Cell
/ genetics
Cell Communication
Cell Line, Tumor
Cell Proliferation
Cell Separation
Clone Cells
/ pathology
Cohort Studies
DNA Copy Number Variations
/ genetics
Epithelium
/ pathology
Female
Gene Amplification
Humans
Kidney Neoplasms
/ genetics
Ligands
Mice, SCID
Models, Biological
Neoplasm Metastasis
/ pathology
Peritoneal Neoplasms
/ secondary
Phenotype
Receptor, ErbB-2
/ genetics
Time Factors
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
16 11 2020
16 11 2020
Historique:
received:
01
07
2020
accepted:
22
10
2020
entrez:
17
11
2020
pubmed:
18
11
2020
medline:
26
11
2020
Statut:
epublish
Résumé
The extent and importance of functional heterogeneity and crosstalk between tumor cells is poorly understood. Here, we describe the generation of clonal populations from a patient-derived ovarian clear cell carcinoma model which forms malignant ascites and solid peritoneal tumors upon intraperitoneal transplantation in mice. The clonal populations are engineered with secreted Gaussia luciferase to monitor tumor growth dynamics and tagged with a unique DNA barcode to track their fate in multiclonal mixtures during tumor progression. Only one clone, CL31, grows robustly, generating exclusively malignant ascites. However, multiclonal mixtures form large solid peritoneal metastases, populated almost entirely by CL31, suggesting that transient cooperative interclonal interactions are sufficient to promote metastasis of CL31. CL31 uniquely harbors ERBB2 amplification, and its acquired metastatic activity in clonal mixtures is dependent on transient exposure to amphiregulin, which is exclusively secreted by non-tumorigenic clones. Amphiregulin enhances CL31 mesothelial clearance, a prerequisite for metastasis. These findings demonstrate that transient, ostensibly innocuous tumor subpopulations can promote metastases via "hit-and-run" commensal interactions.
Identifiants
pubmed: 33199705
doi: 10.1038/s41467-020-19584-1
pii: 10.1038/s41467-020-19584-1
pmc: PMC7669858
doi:
Substances chimiques
Amphiregulin
0
Ligands
0
ERBB2 protein, human
EC 2.7.10.1
Receptor, ErbB-2
EC 2.7.10.1
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
5799Subventions
Organisme : NINDS NIH HHS
ID : P30 NS072030
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA181543
Pays : United States
Organisme : NCI NIH HHS
ID : R33 CA214310
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007133
Pays : United States
Organisme : NCI NIH HHS
ID : R50 CA221675
Pays : United States
Références
Cell. 2014 Aug 28;158(5):1110-1122
pubmed: 25171411
Nature. 2014 Oct 2;514(7520):54-8
pubmed: 25079331
Nat Rev Cancer. 2006 Dec;6(12):924-35
pubmed: 17109012
Gynecol Oncol. 2004 Apr;93(1):170-81
pubmed: 15047232
Cell Prolif. 2012 Aug;45(4):365-77
pubmed: 22607159
Semin Cell Dev Biol. 2014 Apr;28:31-41
pubmed: 24463227
Proc Natl Acad Sci U S A. 2006 Sep 5;103(36):13474-9
pubmed: 16938860
Evolution. 1987 Sep;41(5):1059-1070
pubmed: 28563418
Oncogene. 2014 May 29;33(22):2846-56
pubmed: 23851501
Nat Protoc. 2012 May 03;7(6):1024-41
pubmed: 22555242
Nat Med. 2018 Aug;24(8):1204-1215
pubmed: 29967352
Biol Direct. 2010 Apr 20;5:19; discussion 19
pubmed: 20406436
Int J Epidemiol. 2006 Oct;35(5):1151-9
pubmed: 16987840
Genes Dev. 2010 Aug 15;24(16):1731-45
pubmed: 20713517
Cancer Res. 1984 Jun;44(6):2259-65
pubmed: 6372991
J Clin Invest. 2014 Jun;124(6):2611-25
pubmed: 24762435
Science. 2013 Feb 1;339(6119):543-8
pubmed: 23239622
Oncogene. 2007 Oct 4;26(45):6469-87
pubmed: 17471238
Nat Rev Mol Cell Biol. 2001 Feb;2(2):127-37
pubmed: 11252954
BMC Evol Biol. 2018 Feb 2;18(1):11
pubmed: 29390973
Nat Med. 2015 May;21(5):440-8
pubmed: 25849130
Int J Cancer. 1989 Jan 15;43(1):119-25
pubmed: 2536004
Life Sci. 2019 Nov 1;236:116899
pubmed: 31614145
Proc Natl Acad Sci U S A. 2015 Jan 20;112(3):851-6
pubmed: 25561528
Semin Cell Dev Biol. 2017 Apr;64:79-89
pubmed: 27582427
J Cell Physiol. 2011 Oct;226(10):2691-701
pubmed: 21302279
Cancer Discov. 2011 Jul;1(2):100-2
pubmed: 22013555
FEBS Lett. 2014 Nov 3;588(21):3998-4007
pubmed: 25261255
Nat Protoc. 2009;4(4):582-91
pubmed: 19373229
Curr Biol. 2011 May 10;21(9):779-86
pubmed: 21514161
J Vis Exp. 2012 Feb 17;(60):
pubmed: 22371143
Nat Rev Cancer. 2009 Apr;9(4):274-84
pubmed: 19308067
Cancer Cell. 2011 Feb 15;19(2):244-56
pubmed: 21316603
PLoS One. 2014 Apr 14;9(4):e94476
pubmed: 24732363
Biostatistics. 2004 Oct;5(4):557-72
pubmed: 15475419
Oncogene. 2016 Jan 28;35(4):438-47
pubmed: 25915843
Nature. 2011 Apr 7;472(7341):90-4
pubmed: 21399628
Nature. 2015 Apr 16;520(7547):358-62
pubmed: 25855289
Nat Med. 2015 Jul;21(7):751-9
pubmed: 26099045
Nat Protoc. 2016 Feb;11(2):214-235
pubmed: 26741407
Int J Dev Biol. 1993 Mar;37(1):237-43
pubmed: 8507566
Cell Syst. 2018 Mar 28;6(3):329-342.e6
pubmed: 29550255
Clin Cancer Res. 2011 Mar 15;17(6):1521-34
pubmed: 21411445
Nature. 2012 Aug 23;488(7412):527-30
pubmed: 22854777
Nature. 2009 Jun 18;459(7249):1005-9
pubmed: 19421193
PLoS One. 2015 Jun 04;10(6):e0128066
pubmed: 26043110
Fertil Steril. 1999 Jan;71(1):56-60
pubmed: 9935116
Nat Commun. 2015 Jun 17;6:7419
pubmed: 26080861
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
Oncol Rep. 2009 Aug;22(2):233-40
pubmed: 19578761
Invasion Metastasis. 1983;3(4):234-42
pubmed: 6677628
Nature. 2014 Apr 3;508(7494):113-7
pubmed: 24695311
J Transl Med. 2011 May 27;9:79
pubmed: 21619636
Nat Genet. 2016 Jul;48(7):758-67
pubmed: 27182968
Jpn J Cancer Res. 2002 Nov;93(11):1250-7
pubmed: 12460467
Cell Rep. 2014 Aug 7;8(3):688-95
pubmed: 25066122
Am J Pathol. 2004 Aug;165(2):397-414
pubmed: 15277215
Nature. 2010 Jan 28;463(7280):545-8
pubmed: 20072127
J Biol Chem. 2014 Sep 19;289(38):26178-88
pubmed: 25086039
J Oncol. 2011;2011:591427
pubmed: 21253528
Am J Pathol. 2010 Sep;177(3):1053-64
pubmed: 20651229
J Clin Invest. 2005 Jan;115(1):44-55
pubmed: 15630443
Histopathology. 2018 Nov;73(5):852-863
pubmed: 29989198